• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine- 131-rituximab radio-immunotherapy

MJ Bishton, RJ Hicks, DA Westerman, MH Prince, M Wolf, JF Seymour

Haematologica | FERRATA STORTI FOUNDATION | Published : 2008

DOI: 10.3324/haematol.12253

Open access

University of Melbourne Researchers

David Westerman's Profile Picture
David Westerman Author

Henry Prince's Profile Picture
Henry Prince Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

4Scopus
4Web of Science
4Web of Science
5Dimensions

Keywords

Low-Grade
Hematology
3202 Clinical Sciences
Orphan Drug
Vaccine Related
Chop
Follicular Lymphoma
Science & Technology
I-131 Tositumomab
Molecular Remission
Positron-Emission-Tomography
Immunotherapy
Immunization
32 Biomedical and Clinical Sciences
Rare Diseases
Lymphoma
3211 Oncology and Carcinogenesis
Biomedical Imaging
Life Sciences & Biomedicine
3201 Cardiovascular Medicine and Haematology
Pcr
Cancer
Minimal Residual Disease
Radio-Immunotherapy
Pet
Lymphatic Research

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224